| |
| |
|
| Insider
Information: |
Parsey Merdad |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
111,174 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,453,570 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
111,174 |
|
|
| Total
Value |
$6,453,570 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Medical Officer |
2024-06-10 |
98,380 |
2020-08-15 |
0 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2023-07-18 |
12,794 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2020-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,101 |
5,101 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,455 |
15,718 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,100 |
19,180 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,612 |
44,770 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
42,652 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
43,206 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-11-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,099 |
47,824 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
46,595 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,454 |
81,584 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
32,181 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
72,909 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
72,909 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,401 |
103,107 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2024-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,820 |
100,124 |
0 |
- |
|
| SGMT |
Sagimet Biosciences Inc. |
Director |
– • – |
2023-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,677 |
|
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2020-11-10 |
4 |
D |
$60.62 |
$146,458 |
D/D |
(2,416) |
2,685 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-03-10 |
4 |
D |
$63.91 |
$104,748 |
D/D |
(1,639) |
14,079 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2021-11-10 |
4 |
D |
$67.32 |
$156,182 |
D/D |
(2,320) |
16,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-03-10 |
4 |
D |
$57.92 |
$203,010 |
D/D |
(3,505) |
41,265 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-06-10 |
4 |
D |
$60.74 |
$29,459 |
D/D |
(485) |
42,167 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-09-10 |
4 |
D |
$65.28 |
$31,400 |
D/D |
(481) |
42,725 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-11-10 |
4 |
D |
$82.60 |
$187,337 |
D/D |
(2,268) |
45,556 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2022-12-10 |
4 |
D |
$87.97 |
$42,753 |
D/D |
(486) |
46,109 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-01-24 |
4 |
D |
$84.02 |
$1,491,271 |
D/D |
(17,749) |
82,738 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Medical Officer |
• • – |
2023-03-10 |
4 |
D |
$79.50 |
$423,576 |
D/D |
(5,328) |
76,256 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
